Latest news
Costs of Surveillance Care After Definitive Treatment of Head and Neck Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis - CureusCureus · Mon, 10 Aug 2026 00:26:24 GMTCEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMTLeading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT